Welcome to Add-Aspirin
This website is designed to provide information about the Add-Aspirin Trial, both for people taking part in the trial (participants) and collaborators. Please use the menus at the top of the screen to find out more about the trial.
Add-Aspirin is a large randomised clinical trial, which is taking place in the UK and India. It will recruit 11,000 participants to help find out whether regular aspirin use after treatment for an early stage cancer can prevent the cancer from coming back and preventing deaths.
Congratulations to our top 5 recruiting centres:
- University Hospitals Coventry & Warwickshire
- Worcestershire Royal Hospital
- Bristol Haematology & Oncology Centre
- Royal Lancaster Infirmary
- Queen Elizabeth Hospital King's Lynn & Royal Marsden Hospitals
*FOR GENERAL AND CLINICAL QUERIES, PLEASE CHECK OUR FAQs*
News
Add-Aspirin recruitment continues in India!
Add-Aspirin is now open at 10 centres in India:
- Tata Memorial Hospital, Mumbai
- Chennai Breast Centre
- Jehangir Clinical Development Centre, Pune
- Tata Medical Centre, Kolkata
- Meditrina Institute of Medical Sciences, Nashik
- Shatabdi Hospital, Nagpur
- Vikram & Fortis Hospital, Bengaluru
- Cancer Institute (WIA), Chennai
- Regional Cancer Centre, Trivandrum
- Meenakshi Mission Hospital, Madurai
Quick Links
To RANDOMISE a participant please call +44 (0)20 7670 4777
Trainee Scheme
Trainees: Enhance your research portfolio!
Are you a specialist trainee in medical or clinical oncology, or surgery, and willing to help recruit to the
Add-Aspirin trial?
What's in it for you?
• Gain research experience
• Receive advice on clinical trial recruitment
• Receive a certificate for your training portfolio
Click here to get involved
Breast
We aim to recruit 3100 individuals who have had surgery to remove an early stage breast cancer.
CURRENT STATUS:
OPEN
Detailed eligibility criteria available here
Top recruiters: Worcestershire Royal Hospital, Royal Marsden Hospitals, Churchill Hospital Oxford
PARTICIPANTS REGISTERED: 2179
PARTICIPANTS RANDOMISED: 1707
Colon/Rectum
We aim to to recruit 2600 individuals who have had surgery to remove an early stage bowel cancer.
CURRENT STATUS:
OPEN
Detailed eligibility criteria available here
Top recruiters: Bristol Haematology & Oncology Centre, St James 's University Hospital, Darlington Memorial Hospital
PARTICIPANTS REGISTERED: 1253
PARTICIPANTS RANDOMISED: 972
Gastro
We aim to recruit 2100 individuals who have had surgery or a combination of chemotherapy and radiotherapy to treat a cancer of the stomach or oesophagus (food pipe).
CURRENT STATUS:
OPEN
Detailed eligibility criteria available here
Top recruiters:
The Christie, St James's University Hospital, Leicester Royal Infirmary
PARTICIPANTS REGISTERED: 213
PARTICIPANTS RANDOMISED: 149
Prostate
We aim to recruit 2120 individuals who have had surgery or radiotherapy to treat an early stage prostate cancer.
CURRENT STATUS:
OPEN
Detailed eligibility criteria available here
Top recruiters: UCHW, University Hospital of Wales, Bristol Haematology & Oncology Centre
PARTICIPANTS REGISTERED: 977
PARTICIPANTS RANDOMISED: 781
the trial is being jointly funded by
